CB26259-2 - 0x0000000000003A2C

Study Number: CB26259
Group Number: 2
Study Requirement: Post Menopausal Women
Stipend: up to £ 2,935

Study Criteria:

  • Age: 40 - 70
  • BMI: 18 - 38
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed for the treatment of hot flashes and night sweats assoicated with menopause.
  • Route of Administration: Oral
  • Blood Draws: 45

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One - 13 Night Stay & 1 Return

Screening Dates:

Event Day Event Date Site
Tuesday Dec 11 2018 Belfast

Doctor Exam Dates:

Event Day Event Date Site
Tuesday Dec 11 2018 Belfast

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday Jan 13 2019 5:00PM Saturday Jan 26 2019 8:30AM 1 Belfast
Return Wednesday Jan 30 2019 7:30AM Wednesday Jan 30 2019 8:30AM 1 Belfast